Richmond Medical Clinic
5530 Long Prairie Trace · Richmond, TX 77407
4.7(150 Google reviews · 63 in past year)
Urgent Care Plus and Wellness · 20711 Bellaire Boulevard · Richmond, TX 77407
4.9· 270 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Urgent Care Plus & Wellness is a walk-in urgent care and wellness clinic in Richmond, Texas, serving Katy, Aliana, Sugar Land and the wider West Houston area, according to its website. The site says it was founded by Dr. Luke Afuwape, MD, a board-certified emergency medicine physician, and describes pediatric urgent care, injury treatment, immigration medical exams, hormone optimization and mental health support. Weight-loss care, endocrine care and IV therapy are also listed. Google shows a 4.9-star rating across 270 reviews since 2024, with 51 in the past year, and reviewers most often mention the staff and the providers' knowledge.
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-26. Read the reviews themselves on the practice's Google listing.
Rated ★4.9 across 270 Google reviews. Of the 100 reviews we analyzed, 96 (96%) are positive (4–5★) and 4 (4%) are negative (1–2★).
ax r.★★★★★2026-09-26Great people and staff to work with
Cruz K.★★★★★2026-09-26Very professional & and smooth
Timaat c.★★★★★2026-09-21I had a great experience at this urgent care. Everyone who works there is very nice, accommodating, and attentive. They genuinely take the time to listen and make sure you feel comfortable and cared for. A special thank you to Dr. Cassandra, who was very friendly, caring, and easy to talk to. She made me feel comfortable and took the time to help me understand everything. I really appreciate the excellent care I received, and I will definitely come back again. Highly recommend!
Christina U.★★★★★2026-09-19Cassandra and Lena were professional and attentive. Happen to stop here for a Myers iv therapy. Lena did fantastic at the insertion. I literally felt NOTHING! Casandra explained all precautions and thoroughly went over my vitals and history. I left here feeling like they really cared for my well being. Keep these ladies at this locations at all cost! I’ll be back. Oh and Wednesday they have 30% off IVs! What a deal!
Jessica P.★★★★★2026-09-19This place is great we were treated with respect and courtesy thanks
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
5530 Long Prairie Trace · Richmond, TX 77407
4.7(150 Google reviews · 63 in past year)
10310 West Grand Parkway South · Richmond, TX 77407
4.8(75 Google reviews · 13 in past year)
17627 Beechnut Street · Richmond, TX 77407
4.9(50 Google reviews · 18 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs